W. Ledesma

A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer

G. Wilding, J. Kolesar, K. Wisinski, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result.

A. Onitilo, J. Engel, KyungMann Kim, 2015, The Journal of community and supportive oncology.

A conceptual solution to improve the management of cancer-related breakthrough pain.

T. Campbell, W. Ledesma, 2010, The Journal of Supportive Oncology.